Publication: The benefits of combination therapy with esomeprazole and rebamipide in symptom improvement in reflux esophagitis: An international multicenter study
Issued Date
2016-11-01
Resource Type
ISSN
19762283
DOI
Other identifier(s)
2-s2.0-84992602775
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Gut and Liver. Vol.10, No.6 (2016)
Suggested Citation
Su Jin Hong, Soo Heon Park, Jeong Seop Moon, Woon Geon Shin, Jae Gyu Kim, Yong Chan Lee, Dong Ho Lee, Jae Young Jang, Jae J. Kim, Hang Lak Lee, Sang Woo Lee, Young Hwangbo, Jianming Xu, Bangmao Wang, Zhanxiong Xue, Fei Liu, Yaozong Yuan, Somchai Leelakusolvong, Frederick Dy The benefits of combination therapy with esomeprazole and rebamipide in symptom improvement in reflux esophagitis: An international multicenter study. Gut and Liver. Vol.10, No.6 (2016). doi:10.5009/gnl15537 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/41079
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The benefits of combination therapy with esomeprazole and rebamipide in symptom improvement in reflux esophagitis: An international multicenter study
Other Contributor(s)
Soonchunhyang University, College of Medicine
The Catholic University of Korea, College of Medicine
Inje University Paik Hospital
Hallym University, College of Medicine
Chung-Ang University, College of Medicine
Yonsei University College of Medicine
Seoul National University Bundang Hospital
Kyung Hee University
SungKyunKwan University, School of Medicine
HanYang University, College of Medicine
Korea University Medical Center
Anhui Medical University
Tianjin Medical University
Wenzhou Medical University
Tongji University
Shanghai Jiao Tong University
Mahidol University
University of Santo Tomas Hospital
The Catholic University of Korea, College of Medicine
Inje University Paik Hospital
Hallym University, College of Medicine
Chung-Ang University, College of Medicine
Yonsei University College of Medicine
Seoul National University Bundang Hospital
Kyung Hee University
SungKyunKwan University, School of Medicine
HanYang University, College of Medicine
Korea University Medical Center
Anhui Medical University
Tianjin Medical University
Wenzhou Medical University
Tongji University
Shanghai Jiao Tong University
Mahidol University
University of Santo Tomas Hospital
Abstract
Background/Aims: To investigate the effects of esomeprazole and rebamipide combination therapy on symptomatic improvement in patients with reflux esophagitis. Methods: A total of 501 patients with reflux esophagitis were randomized into one of the following two treatment regimens: 40 mg esomeprazole plus 300 mg rebamipide daily (combination therapy group) or 40 mg esomeprazole daily (monotherapy group). We used a symptom questionnaire that evaluated heartburn, acid regurgitation, and four upper gastrointestinal symptoms. The primary efficacy end point was the mean decrease in the total symptom score. Results: The mean decreases in the total symptom score at 4 weeks were estimated to be -18.1±13.8 in the combination therapy group and -15.1±11.9 in the monotherapy group (p=0.011). Changes in reflux symptoms from baseline after 4 weeks of treatment were -8.4±6.6 in the combination therapy group and -6.8±5.9 in the monotherapy group (p=0.009). Conclusions: Over a 4-week treatment course, esomeprazole and rebamipide combination therapy was more effective in decreasing the symptoms of reflux esophagitis than esomeprazole monotherapy.